Sutro Biopharma, Inc. (STRO): Depreciation & Amortization
$7.32M
Year ended 2025-12-31
$6.06M
Trailing 12 months to 2026-06-30
+8.8%
3-year compound annual growth
+11.3%
5-year compound annual growth
| Period ended | Depreciation & Amortization | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $7.32M | +1.5% | 2026-03-23, From 2025-01-01 |
| 2024-12-31 | $7.22M | +5.9% | 2026-03-23, From 2024-01-01 |
| 2023-12-31 | $6.82M | +19.8% | 2025-03-13, From 2023-01-01 |
| 2022-12-31 | $5.69M | +17.5% | 2025-03-13, From 2022-01-01 |
| 2021-12-31 | $4.84M | +12.7% | 2024-03-25, From 2021-01-01 |
| 2020-12-31 | $4.30M | -10.0% | 2023-03-30, From 2020-01-01 |
| 2019-12-31 | $4.78M | +5.2% | 2022-02-28, From 2019-01-01 |
| 2018-12-31 | $4.54M | -9.0% | 2021-03-18, From 2018-01-01 |
| 2017-12-31 | $4.99M | -11.9% | 2020-03-16, From 2017-01-01 |
| 2016-12-31 | $5.66M | n/a | 2019-04-01, From 2016-01-01 |
Depreciation & Amortization at similar companies
| Company | Year ended | Depreciation & Amortization | Change YoY |
|---|---|---|---|
| Sutro Biopharma, Inc. (STRO) | 2025-12-31 | $7.32M | +1.5% |
| ImmunityBio, Inc. (IBRX) | 2025-12-31 | $15.53M | -11.6% |
| Agenus Inc (AGEN) | 2025-12-31 | $10.00M | -25.1% |
| Atara Biotherapeutics, Inc. (ATRA) | 2025-12-31 | $2.12M | -58.1% |
| 4D Molecular Therapeutics, Inc. (FDMT) | 2025-12-31 | $4.69M | +0.9% |
| MeiraGTx Holdings plc (MGTX) | 2025-12-31 | $12.54M | -2.2% |
| Autolus Therapeutics plc (AUTL) | 2025-12-31 | $8.30M | +9.8% |
| Beam Therapeutics Inc. (BEAM) | 2025-12-31 | $22.29M | +1.7% |
| Recursion Pharmaceuticals, Inc. (RXRX) | 2025-12-31 | $83.70M | +129.4% |
Compare STRO, IBRX, AGEN, ATRA side by side · Screen every company in Biological Products, (No Diagnostic Substances) ↗